The epidemiology of invasive Haemophilus influenzae non-serotype B disease in Ontario, Canada from 2004 to 2013

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Desai, Shalini ^a   Jamieson, Frances B ^a,b   Patel, Samir N ^a,b   Seo, Chi Yon ^a   Dang, Vica ^a   Fediurek, Jill ^a   Navaranjan, Debeka ^a   Deeks, Shelley L ^a,c  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFACLOR; CEFTRIAXONE; CLARITHROMYCIN; LEVOFLOXACIN; MEROPENEM; SULTAMICILLIN; HAEMOPHILUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; CHILD; DISEASE SURVEILLANCE; DRUG EFFECT; ETHNICITY; HAEMOPHILUS INFECTION; HUMAN; INFANT; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; NONTYPEABLE HAEMOPHILUS INFLUENZAE SEROTYPE B; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; TREND STUDY; VERY ELDERLY; YOUNG ADULT; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; IC50; IMMUNOLOGY; INCIDENCE; MALE; MICROBIOLOGY; NEWBORN; ONTARIO; POISSON DISTRIBUTION; SEROTYPE; SEROTYPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPICILLIN; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INHIBITORY CONCENTRATION 50; MALE; MIDDLE AGED; ONTARIO; POISSON DISTRIBUTION; SEROGROUP; SEROTYPING; YOUNG ADULT;

EID: 84957111633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142179     Document Type: Article

References (34)

1. Immunize Canada. Haemophilus Influenzae type b (Hib). 2013. Available: http://www.immunize.ca/en/diseases-vaccines/haemophilus-influenzae-type-b.aspx.
2. Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010; 28: 4073-4078. doi: 10.1016/j.vaccine.2010.03.075 PMID: 20398617
3. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA. 1985; 253: 521-529. PMID: 3918181
4. Public Health Agency of Canada. Notifiable Diseases On-Line-Invasive Haemophilus influenzae, type b disease. Available: http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/charts.php?c=pl.
5. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993; 269: 221-226. PMID: 8417239
6. UK Health Protection Agency. Graph showing Haemophilus influenzae type b laboratory reports: England, 1990-2012. Available: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317140385307.
7. Statistics Canada. Population by year, by province and territory. Available: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo02a-eng.htm.
8. Ontario Agency for Health Protection and Promotion. Reportable Disease Trends in Ontario 2013. Available: http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/Documents/AER/story.html.
9. MacNeil JR, Cohn AC, Farley M, Mair R, Baumbach J, Bennett N, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease-United States, 1989-2008. Clin Infect Dis. 2011; 53: 1230-1236. doi: 10.1093/cid/cir735 PMID: 22080119
10. Berndsen MR, Erlendsdottir H, Gottfredsson M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clin Microbiol Infect. 2012; 18: 918-923. doi: 10.1111/j.1469-0691.2011.03700.x PMID: 22070637
11. Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013; 32: 805-809. doi: 10.1097/INF.0b013e31828d9acc PMID: 23860479
12. Setchanova LP, Kostyanev T, Alexandrova AB, Mitov IG, Nashev D, Kantardjiev T. Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. Ann Clin Microbiol Antimicrob. 2013; 12: 6-0711-12-6.
13. Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natas OB, Steinbakk M, et al. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. Euro Surveill. 2014; 19: 20986. PMID: 25523969
14. Pfaller MA, Farrell DJ, Sader HS, Jones RN. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Clin Infect Dis. 2012; 55 Suppl 3: S187-93. doi: 10.1093/cid/cis561 PMID: 22903951
15. Killian M, Murray P, Baron E, Jorgensen J, Landry M, Pfaller M, editors. Manual of Clinical Microbiology-Haemophilus. 9th ed. Washington: ASM Press; 2007.
16. Clinical and Laboratory Standards Institute. M100-S25: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. 2015.
17. Hajjeh RA, Privor-Dumm L, Edmond K, O'Loughlin R, Shetty S, Griffiths UK, et al. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. Vaccine. 2010; 28: 7123-7129. doi: 10.1016/j.vaccine.2010.07.028 PMID: 20659515
18. Hajjeh R, Mulholland K, Schuchat A, Santosham M. Progress towards demonstrating the impact of Haemophilus influenzae type b conjugate vaccines globally. J Pediatr. 2013; 163: S1-3. doi: 10.1016/j. jpeds.2013.03.022 PMID: 23773587
19. Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, et al. Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infect Dis. 2010; 16: 455-463. doi: 10.3201/eid1603. 090290 PMID: 20202421
20. Wan Sai Cheong J, Smith H, Heney C, Robson J, Schlebusch S, Fu J, et al. Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)? Epidemiol Infect. 2015: 1-8.
21. Tsang RS, Sill ML, Skinner SJ, Law DK, Zhou J, Wylie J. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis. 2007; 44: 1611-1614. PMID: 17516405
22. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2: S27-72. PMID: 17278083
23. Agrawal A, Murphy TF. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol. 2011; 49: 3728-3732. doi: 10.1128/JCM.05476-11 PMID: 21900515
24. Resman F, Ristovski M, Ahl J, Forsgren A, Gilsdorf JR, Jasir A, et al. Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin Microbiol Infect. 2011; 17: 1638-1645. doi: 10.1111/j.1469-0691.2010.03417.x PMID: 21054663
25. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis. 2007; 44: 810-816. PMID: 17304452
26. Bruce MG, Zulz T, DeByle C, Singleton R, Hurlburt D, Bruden D, et al. Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011. Emerg Infect Dis. 2013; 19: 932-937. doi: 10.3201/eid1906.121805 PMID: 23735653
27. Rotondo JL, Sherrard L, Helferty M, Tsang R, Desai S. The epidemiology of invasive disease due to Haemophilus influenzae serotype a in the Canadian North from 2000 to 2010. Int J Circumpolar Health. 2013; 72: doi: 10.3402/ijch.v72i0.21142 eCollection 2013.
28. Brown VM, Madden S, Kelly L, Jamieson FB, Tsang RS, Ulanova M. Invasive Haemophilus influenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002-2008. Clin Infect Dis. 2009; 49: 1240-1243. doi: 10.1086/605671 PMID: 19761408
29. Statistics Canada. Aboriginal Peoples in Canada: First Nations People, Métis and Inuit.
30. Van Eldere J, Slack MP, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014; 14: 1281-1292. doi: 10.1016/S1473-3099(14)70734-0 PMID: 25012226
31. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39: 1267-1284. PMID: 15494903
32. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41: 580-637. doi: 10.1097/CCM.0b013e31827e83af PMID: 23353941
33. Resman F, Ristovski M, Forsgren A, Kaijser B, Kronvall G, Medstrand P, et al. Increase of beta-lactamresistant invasive Haemophilus influenzae in Sweden, 1997 to 2010. Antimicrob Agents Chemother. 2012; 56: 4408-4415. doi: 10.1128/AAC.00415-12 PMID: 22687505
34. Baretto L. Canadian Immunization Conference 2014 Presentation: New vaccines for Canada. 2014.